Advanced search

Instruments

Name		Stock exchange	Average volume	Price	Type
HASEGAWA CO., LTD.	8230	Japan Exchange +1 Other	21,007	345 JPY	Stock
HASEGAWA CO., LTD.	8230	Fukuoka Stock Exchange	0	328 JPY
T. HASEGAWA CO., LTD.	4958	Japan Exchange +1 Other	54,043	3,085 JPY	Stock
T. HASEGAWA CO., LTD.	HASGF	OTC Markets	0	24.37 USD

News (45)

AGC : Changes in the Board of Directors, Corporate Auditors and Executive Officers(PDF 97KB)	21-12-09	PU
AGC : Changes in the Board of Directors and Executive Officers(PDF 93KB)	20-12-10	PU
AGC : Changes in the Board of Directors and Executive Officers (PDF 156KB)	19-12-09	PU
Takeda Pharmaceutical : shareholder group aims to block $62 billion Shire deal	18-06-11	RE
Takeda Pharmaceutical : shareholder group aims to block $62 billion Shire deal	18-06-11	RE
Takeda Pharmaceutical : Shire bid marks Takeda's latest - and biggest - push for global status	18-04-25	RE
Asahi Glass : Changes in the Audit & Supervisory Board Members and Executive Officers (PDF 58KB)	17-12-12	PU
Takeda Pharmaceutical Company Limited Announces Executive and Directorate Changes	17-04-13	CI
Asahi Glass : Changes in the Members of the Board of Directors,Corporate Auditors and Executive Officers	16-12-13	PU
Takeda Pharmaceutical : Announces New Assignment of Directors	16-06-29	PU
Takeda Pharmaceutical : Announces Candidates for New Directors after the Transition to a Company with Audit and Supervisory	16-05-10	PU
Takeda Pharmaceutical : Announces New Assignment of Directors	15-06-26	PU
Takeda Pharmaceutical Company Limited Announces Executive Appointments	15-06-25	CI
Tokyo Electric Power Company Announces Executive Changes	15-06-24	CI
Tokyo Electric Power Company Announces Board Changes	15-03-16	CI
Takeda Pharmaceutical Company Limited Announces Executive Changes	15-03-04	CI
Transcript : Takeda Pharmaceutical Company Limited, Q2 2015 Earnings Call, Oct 30, 2014	14-10-30
Takeda Pharmaceutical Company Limited Announces New Assignment of Directors	14-06-26	CI
Otsuka : and Takeda Announce a Co-promotion Agreement in Japan of TAK-438 for the Treatment of Acid-related Diseases in the Gastrointestinal Therapeutic Area (119KB)	14-03-27	PU
Takeda Pharmaceutical Company Limited Announces Management Changes	14-02-28	CI
Takeda Pharmaceutical Co Ltd : Takeda Announces Mr. Christophe Weber Begins as Takeda's Chief Operating Officer (COO) on April 1st	14-02-28	PU
Takeda Pharmaceuticals Announces Management Changes	13-12-04	CI
Takeda Pharmaceutical Company Limited : Takeda Appoints Chief Operating Officer	13-11-29	PU
U.S. Senate Committee on Finance : Baucus Says Trans-Pacific Partnership, Trade Promotion Authority Are Critical to a Job-Creating Trade Agenda	13-11-14	PU
Transcript : Takeda Pharmaceutical Company Limited, H1 2014 Earnings Call, Oct 31, 2013	13-10-31
KISSEI PHARMACEUTICAL CO.,LTD. : Approval of Partial Changes of Indication of Glufast® in Japan	13-09-13	PU
Takeda Pharmaceutical Company Limited : Approval of Partial Changes of Indication of Glufast® in Japan	13-09-13	PU
Taisho Pharma : Notice of Acquisition of an Exclusive Distributorship for Products of Biofermin Pharmaceutical Co., Ltd. and Purchase of a Part of its Shares by Taisho Pharmaceutical Co., Ltd.(Taisho Pharmaceutical Holdings)	13-07-31	PU
Rakuten, Inc. : As Japan PM Abe weighs labor reform, IBM emerges as test case	13-07-09	RE
Transcript : Takeda Pharmaceutical Company Limited, 2013 Earnings Call, May 09, 2013	13-05-09
Transcript : Takeda Pharmaceutical Company Limited, 2013 Earnings Call, May 09, 2013	13-05-09
Takeda Pharmaceutical Company Limited : AnnouncesFinancial Results for the Fiscal Year Ended March 31, 2013 andForecasts for the Fiscal Year Ending March 31, 2014	13-05-09	PU
Takeda Pharmaceutical Company Limited : Approval of a Once-Monthly Formulation of Risedronate Sodium Hydrate, an Antiosteoporotic Agent in Japan	12-12-25	PU
Eisai Co., Ltd : Approval of a Once-Monthly Formulation of Risedronate Sodium Hydrate,an Antiosteoporotic Agent in Japan	12-12-25	PU
Transcript : Takeda Pharmaceutical Company Limited, Q2 2013 Earnings Call, Oct 31, 2012	12-10-31
Takeda Pharma : September 12, 2012 Takeda Completes its Russian Pharmaceutical Manufacturing Facility	12-09-11	PU
Delegation of the European Commission in Tokyo, Ja : European Commissioner for employment issues to visit Japan	12-07-11	PU
Takeda Pharma : March 26, 2012 Ajinomoto Pharmaceuticals Co., Ltd. and Takeda Submit Application for a Once-Monthly Formulation of Risedronate Sodium Hydrate for the Treatment of Osteoporosis in Japan	12-03-26	PU
Takeda Pharma : January 18, 2012 Takeda Announces Strategic Measures to Achieve Efficiencies for Long-Term Growth	12-01-18	PU
TAKEDA PHARM.CO.LTD.YN 50 : June 15, 2011 Takeda to Start Internship Program for Tsinghua University of China	11-06-15	PU
BAXTER INTL : Baxter and Takeda Complete Agreement for Vero Cell-Based Influenza Vaccines in Japan	10-12-02	BU
AMYLIN PHARM : Amylin Pharmaceuticals and Takeda Enter into Worldwide Agreement to Co-Develop and Commercialize Compounds for Obesity	09-11-01	PR
Millennium Pharm : Takeda Completes Acquisition of Millennium	08-05-14	PR
Millennium Pharm : Takeda to Acquire Millennium for US$25.00 Per Share in an All Cash Tender Offer Valued at $8.8 Billion	08-04-10	PR
Affymax Inc : Affymax(R) and Takeda Honored with the Allicense 2007 Breatkthrough Alliance Award for Their Exclusive Global Agreement for Hematide(TM)	07-04-18	BU

12NextSee all

Companies (1)

HASEGAWA CO., LTD. 39 M $

HASEGAWA CO., LTD. is a Japan-based company principally engaged in the religious product related business. The Company operates in two business segments. The Buddhist Altars, Fittings and Gravestones segment is engaged in the retails of Buddhist altars, f ...

Insiders

Yasuchika Hasegawa

Yasuchika Hasegawa is on the board of AGC, Inc. (Japan). In the past Mr. Hasegawa occupied the position of Chairman of Takeda Pharmaceutical Co., Ltd., President of TAP Pharmaceutical Products, Inc., President for TAP Holdings LLC and Chairman of Japan Association of Corporate Executives. He received an undergraduate degree from Waseda University.

Yasuchika Uechi

Yasuchika Iwasa

Yasuchika Iwasa is currently the President & Representative Director at Nippo Ltd.
He previously served as the Chairman at Nippo (Hong Kong) Ltd.

Yasuchika Takahashi worked at Oita Bank, Ltd.
from 1958 to 2011.
He held the position of Director in 2010-2011.

Yasuchika Wakayama

Yasuchika Noma

No results for this search

Stock Market
Advanced search
Yasuchika Hasegawa